GO:0006203 dGTP catabolic process: Nucleotide Pool Sanitization, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006203 dGTP catabolic process describes the biochemical breakdown of deoxyguanosine triphosphate (dGTP) into downstream metabolites, a key arm of nucleotide pool homeostasis.
• Loss of dGTP catabolic capacity, as seen with RRM2B deficiency, causes dATP and dGTP depletion through enhanced degradation and slower synthesis, linking catabolism directly to mitochondrial nucleotide supply.
• The MTH1 (NUDT1) enzyme sanitizes oxidized dGTP (8-oxo-dGTP) by hydrolyzing it to 8-oxo-dGMP, preventing its incorporation into DNA.
• Bacterial dGTP starvation and its suppression reveal that dGTP catabolic and salvage pathways are tightly interconnected with de novo synthesis in Escherichia coli.
• Altered dNTP pools, including dGTP, accelerate tumor formation in mice, establishing dGTP catabolism as a modifier of genome stability and cancer risk.
• Purine nucleoside phosphorylase (PNP) deficiency illustrates how defective purine catabolism causes immune and neurological disease, providing a clinical template for studying dGTP breakdown.
Description
The dGTP catabolic process (GO:0006203) is the set of biochemical reactions that degrade deoxyguanosine triphosphate (dGTP) into lower-order purine nucleotides and nucleosides. It is a core component of nucleotide pool sanitation, ensuring that dGTP and its oxidized derivatives do not accumulate to mutagenic or cytotoxic levels. Because dGTP is both a DNA precursor and a signaling-relevant metabolite, its catabolism is intimately linked to DNA replication fidelity, mitochondrial nucleotide homeostasis, and redox biology. Researchers study dGTP catabolism to understand how cells balance de novo synthesis, salvage, and degradation of guanine nucleotides. In mammalian cells, the cytosolic and mitochondrial dNTP pools are maintained by a coordinated network of synthetic and catabolic enzymes; disruption of this network, for example by RRM2B deficiency, leads to dATP and dGTP depletion through enhanced degradation and slower synthesis. In bacteria, dGTP starvation and its genetic suppressors have been used to dissect how catabolic and salvage routes buffer dGTP supply. From a disease perspective, dGTP catabolism intersects with cancer, cardiovascular disease, and inherited purine disorders. Altered dNTP pools accelerate tumor formation in mice, while guanosine oxidation products contribute to cardiovascular pathology. Defects in purine catabolism, such as PNP deficiency, cause severe immune and neurological phenotypes. Understanding GO:0006203 therefore provides a mechanistic handle on genome stability, oxidative stress responses, and therapeutic targeting of nucleotide metabolism.
dGTP catabolic process At A Glance
| GO ID | GO:0006203 |
|---|---|
| GO term | dGTP catabolic process |
| Ontology | biological_process |
| Synonym | dGTP breakdown; dGTP catabolism; dGTP degradation |
| Major function | Breakdown of dGTP to maintain balanced deoxynucleotide pools and prevent mutagenic incorporation |
| Key enzymes | MTH1 (NUDT1), RRM2B-associated pathways, purine nucleoside phosphorylase (PNP), bacterial dGTPases |
| Substrates | dGTP, 8-oxo-dGTP, and related oxidized guanine nucleotides |
| Disease relevance | Cancer, cardiovascular disease, PNP deficiency, mitochondrial depletion syndromes |
| Research methods | CRISPR knockout, metabolic labeling, dNTP pool quantification, enzyme assays, Ribo-seq/RNA-seq |
What Is GO:0006203?
In our own words, GO:0006203 dGTP catabolic process encompasses the chemical reactions and pathways that result in the breakdown of dGTP (deoxyguanosine triphosphate). This includes enzymatic hydrolysis of the triphosphate chain, dephosphorylation to dGDP and dGMP, and further degradation of the guanine base or its oxidized forms. The term is a biological_process in the Gene Ontology and is synonymous with dGTP breakdown, dGTP catabolism, and dGTP degradation.
Why Is dGTP catabolic process Important in Cell Biology?
dGTP catabolic process is important because it controls the cellular concentration of a highly mutagenic nucleotide precursor. When dGTP or its oxidized form 8-oxo-dGTP accumulates, it can be misincorporated into DNA, causing transversions and genome instability. Conversely, excessive catabolism can deplete dGTP needed for mitochondrial DNA replication, as observed in RRM2B deficiency where dATP and dGTP are depleted through enhanced degradation and slower synthesis. Thus, GO:0006203 sits at the crossroads of genome maintenance, mitochondrial function, and disease risk, including cancer and cardiovascular pathology.
• Maintains dNTP pool balance to support accurate DNA replication and repair.
• Prevents incorporation of oxidized dGTP (8-oxo-dGTP) into DNA, reducing mutagenesis.
• Links mitochondrial nucleotide homeostasis to dGTP catabolism via RRM2B.
• Modulates tumor formation, as altered dNTP pools accelerate cancer in mouse models.
• Contributes to cardiovascular disease through guanosine oxidation and nucleotide catabolism.
• Provides a mechanistic basis for understanding PNP deficiency and purine catabolic disorders.
• Informs antibacterial strategies by targeting bacterial dGTP starvation and salvage pathways.
• Supports development of CRISPR models to dissect gene function in nucleotide metabolism.
• Guides biomarker discovery for diseases linked to nucleotide pool imbalance.
• Enables metabolic engineering and synthetic biology applications involving dGTP-dependent processes.
What Happens During dGTP catabolic process?
Substrate recognition and initial hydrolysis
In simple terms: The cell first identifies dGTP or its oxidized form and starts breaking it down.
The dGTP catabolic process begins with recognition of dGTP or oxidized derivatives such as 8-oxo-dGTP by sanitizing enzymes. MTH1 (NUDT1) hydrolyzes oxidized dGTP to 8-oxo-dGMP, preventing its incorporation into DNA. This step is critical because 8-oxo-dGTP can pair with adenine and cause transversions. In bacteria, dGTP starvation experiments have revealed that catabolic and salvage enzymes compete for dGTP, influencing its availability.
Dephosphorylation to dGDP and dGMP
In simple terms: After the first cut, the molecule loses phosphate groups step by step.
Following initial hydrolysis, dGTP is dephosphorylated to dGDP and then dGMP. These reactions are part of the broader purine nucleotide catabolic network. In mammalian cells, RRM2B deficiency enhances dGTP degradation, contributing to dATP and dGTP depletion. This demonstrates that dephosphorylation is not merely a disposal route but a regulated process that can deplete precursor pools.
Nucleoside formation and base release
In simple terms: The phosphate-stripped nucleotide is converted into a nucleoside and then the free base.
dGMP is further dephosphorylated to deoxyguanosine, which can be cleaved by purine nucleoside phosphorylase (PNP) to release guanine. PNP deficiency in humans causes severe immune and neurological disease, underscoring the importance of this catabolic step. The released guanine can be salvaged or further degraded, linking dGTP catabolism to purine recycling.
Oxidative damage surveillance
In simple terms: The pathway also cleans up damaged versions of dGTP before they can hurt DNA.
Oxidative stress generates 8-oxo-dGTP, which is a substrate for MTH1. MTH1 acts as a nucleotide pool sanitizing enzyme, and its role in cancer is context-dependent, sometimes protecting and sometimes promoting tumorigenesis. The balance between dGTP synthesis, oxidation, and catabolism determines whether oxidized guanine nucleotides are detoxified or incorporated into DNA.
Integration with de novo synthesis and salvage
In simple terms: Breakdown is coordinated with production so the cell always has the right amount of dGTP.
dGTP catabolism is not isolated; it is integrated with de novo synthesis and salvage pathways. In E. coli, suppressors of dGTP starvation map to genes that alter dGTP supply, showing that catabolic flux can compensate for synthetic defects. In mammalian cells, RRM2B deficiency shifts the balance toward degradation, reducing dGTP and dATP pools. This integration ensures that dGTP levels are maintained within a narrow range compatible with genome stability.
Key Genes Involved in GO:0006203 dGTP catabolic process
The following genes and proteins are experimentally implicated in dGTP catabolic process or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTH1 (NUDT1) | Hydrolyzes oxidized dGTP (8-oxo-dGTP) to 8-oxo-dGMP | Nucleotide pool sanitization; cancer context-dependence |
| RRM2B | Maintains dNTP pools; deficiency enhances dGTP degradation | Mitochondrial depletion syndromes; dATP/dGTP depletion |
| PNP | Purine nucleoside phosphorylase; cleaves deoxyguanosine | PNP deficiency; immune and neurological disease |
| NUDT1 | Alternative symbol for MTH1; sanitizes oxidized nucleotides | Oxidative damage prevention |
| ITPA | Inosine triphosphatase; related nucleotide sanitation | Nucleotide pool homeostasis |
| DGUOK | Deoxyguanosine kinase; phosphorylates deoxyguanosine | Mitochondrial dNTP supply |
| TK2 | Thymidine kinase 2; mitochondrial dNTP salvage | Mitochondrial nucleotide metabolism |
| GUK1 | Guanylate kinase; converts GMP to GDP | Guanine nucleotide metabolism |
| NT5C | Cytosolic 5'-nucleotidase; dephosphorylates dGMP | Purine catabolism |
| NT5M | Mitochondrial 5'-nucleotidase | Mitochondrial dNTP catabolism |
| SAMHD1 | dNTP triphosphohydrolase; regulates dNTP pools | dNTP pool control; innate immunity |
| ADA | Adenosine deaminase; purine catabolism | Purine catabolic disorders |
| XDH | Xanthine dehydrogenase; purine degradation | Purine catabolism |
| HPRT1 | Hypoxanthine phosphoribosyltransferase; salvage | Purine salvage and catabolism |
| E. coli dGTPase | Hydrolyzes dGTP in bacteria | dGTP starvation and suppression |
| E. coli Gsk | Guanosine kinase; salvage | dGTP supply in bacteria |
| E. coli Hpt | Hypoxanthine phosphoribosyltransferase | Purine salvage |
| E. coli PurF | De novo purine synthesis | dGTP synthesis and starvation |
How Is dGTP catabolic process Regulated?
dGTP catabolic process is regulated at multiple levels. In mammalian cells, RRM2B is a key regulator of dNTP pools; its deficiency enhances dGTP degradation and slows synthesis, leading to dATP and dGTP depletion. Oxidative stress regulates MTH1 expression and activity, which in turn controls the catabolism of oxidized dGTP. In bacteria, dGTP starvation induces adaptive responses, and suppressors can restore growth by altering catabolic or salvage flux. Additionally, altered dNTP pools in mice accelerate tumor formation, indicating that catabolic regulation influences cancer risk. These layers of regulation ensure that dGTP catabolism is tuned to DNA replication demand and redox status.
dGTP catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RRM2B | Mitochondrial dNTP depletion; dGTP/dATP imbalance | RRM2B knockout or point-mutation cell lines |
| MTH1 (NUDT1) | Cancer; oxidative nucleotide damage | MTH1 knockout and overexpression models |
| PNP | PNP deficiency; immune and neurological disease | PNP knockout mice or patient-derived cells |
| SAMHD1 | dNTP pool regulation; cancer and innate immunity | SAMHD1 knockout cell lines |
| E. coli dGTPase | Bacterial dGTP starvation | E. coli dGTPase mutants |
Cancer and genome instability
Altered dNTP pools, including dGTP, accelerate tumor formation in mice, linking dGTP catabolic process to cancer risk. MTH1, a key sanitizing enzyme, can either protect against or promote cancer depending on context, making it a debated therapeutic target. Oxidative nucleotide damage, if not repaired or catabolized, drives mutations that contribute to oncogenesis.
Mitochondrial depletion syndromes
RRM2B deficiency causes dATP and dGTP depletion through enhanced degradation and slower synthesis, resulting in mitochondrial nucleotide imbalance. This connects dGTP catabolism to mitochondrial DNA maintenance disorders and provides a model for studying how catabolic flux affects organelle function.
Cardiovascular disease
DNA and RNA guanosine oxidation, including the formation of oxidized guanine nucleotides, plays a role in cardiovascular diseases. The catabolism of oxidized dGTP by MTH1 and related enzymes may modulate oxidative stress responses in the vasculature.
PNP deficiency and immune disorders
Purine nucleoside phosphorylase (PNP) deficiency impairs purine catabolism, leading to immune deficiency and neurological symptoms. Although PNP acts downstream of dGTP, its deficiency illustrates how defective catabolism of guanine nucleotides causes human disease.
From dGTP catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter dGTP catabolism? | CRISPR knockout cell line |
| Does a specific point mutation affect enzyme activity? | Point-mutation knock-in |
| Can a tagged enzyme be used to measure catabolic flux? | Tagged knock-in |
| Does overexpression of a sanitizing enzyme reduce mutagenesis? | Overexpression cell model |
| Which genes buffer dGTP starvation? | Bacterial suppressor screens |
| Does altered dGTP catabolism accelerate tumor formation? | Mouse models with altered dNTP pools |
How to Study the dGTP catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| dNTP pool quantification | Cellular dGTP, dATP, and other dNTP levels | Assessing catabolic flux and pool imbalance |
| Enzyme activity assay | Hydrolysis rate of dGTP or 8-oxo-dGTP | Characterizing MTH1 or dGTPase function |
| CRISPR knockout screen | Gene requirements for dGTP homeostasis | Identifying novel regulators |
| RNA-seq | Transcriptional changes in nucleotide metabolism | Mapping regulatory responses |
| Proteomics | Protein expression and modification | Detecting pathway rewiring |
| Metabolic labeling | Flux through dGTP synthesis and catabolism | Tracing nucleotide turnover |
| Mouse tumor models | Tumor formation under altered dNTP pools | Linking dGTP catabolism to cancer |
| Bacterial genetics | Suppressors of dGTP starvation | Dissecting catabolic-salvage balance |
dNTP pool quantification
Measuring dGTP and other dNTP levels is essential to assess catabolic flux. RRM2B deficiency was shown to deplete dATP and dGTP using such methods. Altered dNTP pools in mice were also quantified to link pool imbalance to tumor formation.
Enzyme activity assays
In vitro assays with purified MTH1 or bacterial dGTPases can measure hydrolysis of dGTP and 8-oxo-dGTP. These assays help determine kinetic parameters and inhibitor sensitivity.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes that modify dGTP catabolism or sensitivity to dGTP starvation. Such screens are powerful for discovering novel regulators.
Transcriptomics and proteomics
RNA-seq and proteomics can reveal expression changes in nucleotide metabolism genes under oxidative stress or dGTP depletion. These approaches help map regulatory networks around GO:0006203.
How CRISPR Can Be Used to Study GO:0006203 dGTP catabolic process
Knockout
CRISPR knockout of genes such as RRM2B or MTH1 can reveal their roles in dGTP catabolism. RRM2B deficiency enhances dGTP degradation and depletes dATP/dGTP pools. MTH1 knockout increases sensitivity to oxidative stress and alters mutagenesis.
Point Mutation
Point mutations in catalytic residues of MTH1 or bacterial dGTPases can separate hydrolysis from substrate binding. Such models help define structure-function relationships in dGTP catabolism.
Knock-in
Tagged knock-in of catabolic enzymes enables live-cell imaging and proteomic analysis of dGTP catabolism. This approach can track enzyme localization and interactions.
Overexpression
Overexpression of MTH1 or other sanitizing enzymes can test whether enhanced catabolism protects against oxidative DNA damage or, conversely, promotes tumorigenesis. Overexpression models are also useful for drug screening.
How EDITGENE Supports dGTP catabolic process Research
Researchers studying dGTP catabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide pool regulation, oxidative damage prevention, or disease progression. EDITGENE provides CRISPR-based cell models and screening services to accelerate this work.
Contact EDITGENE today to design your custom CRISPR model for dGTP catabolic process research.
Frequently Asked Questions About dGTP catabolic process
What is dGTP catabolic process?
dGTP catabolic process (GO:0006203) is the set of biochemical reactions that break down deoxyguanosine triphosphate (dGTP) into lower-order nucleotides and nucleosides, helping maintain balanced dNTP pools.
What genes are involved in dGTP catabolic process?
Key genes include MTH1 (NUDT1), RRM2B, PNP, and bacterial dGTPases, all of which have been experimentally linked to dGTP breakdown or pool regulation.
Why is dGTP catabolism important for genome stability?
It prevents accumulation of dGTP and oxidized 8-oxo-dGTP, which can be misincorporated into DNA and cause mutations.
How does RRM2B deficiency affect dGTP?
RRM2B deficiency causes dATP and dGTP depletion through enhanced degradation and slower synthesis.
What is the role of MTH1 in dGTP catabolism?
MTH1 hydrolyzes oxidized dGTP (8-oxo-dGTP) to 8-oxo-dGMP, sanitizing the nucleotide pool and preventing oxidative DNA damage.
Can altered dGTP catabolism cause cancer?
Altered dNTP pools, including dGTP, accelerate tumor formation in mice, suggesting that dGTP catabolism influences cancer risk.
How do researchers study dGTP catabolic process?
Common methods include dNTP pool quantification, enzyme activity assays, CRISPR knockout screens, and transcriptomics.
What diseases are linked to dGTP catabolism?
Cancer, mitochondrial depletion syndromes, cardiovascular disease, and PNP deficiency have been linked to dGTP catabolism or related nucleotide pool imbalance.
What is the GO ID for dGTP catabolic process?
The Gene Ontology ID is GO:0006203, classified under biological_process.
How can CRISPR help study dGTP catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of gene function in dGTP catabolic pathways.
Conclusion
dGTP catabolic process (GO:0006203) is a critical biological process that maintains nucleotide pool balance, prevents oxidative DNA damage, and influences cancer and mitochondrial disease. Key enzymes such as MTH1, RRM2B, and PNP have been experimentally linked to dGTP breakdown and its disease consequences. Understanding this pathway offers opportunities for therapeutic targeting and biomarker development. CRISPR-based models are indispensable for dissecting the causal roles of genes in dGTP catabolism. By combining knockout, point mutation, knock-in, and overexpression strategies with metabolic and genomic readouts, researchers can uncover new regulators and translate findings into clinical applications.
References
- 1. Awoyomi OF et al.. 2025. RRM2B deficiency causes dATP and dGTP depletion through enhanced degradation and slower synthesis.. Proc Natl Acad Sci U S A 122(16):e2503531122 PMID: 40244665
- 2. Chen HY et al.. 2023. Progress on Z genome biosynthetic pathway of bacteriophage.. Yi Chuan 45(10):887-903 PMID: 37872112
- 3. Tran P et al.. 2024. Altered dNTP pools accelerate tumor formation in mice.. Nucleic Acids Res 52(20):12475-12486 PMID: 39360631
- 4. Sekiguchi M et al.. 2002. Oxidative nucleotide damage: consequences and prevention.. Oncogene 21(58):8895-904 PMID: 12483507
- 5. Li Y et al.. 2024. The role of DNA and RNA guanosine oxidation in cardiovascular diseases.. Pharmacol Res 204:107187 PMID: 38657843
- 6. Nakabeppu Y et al.. 2017. MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe?. Free Radic Biol Med 107:151-158 PMID: 27833032
- 7. Sato T et al.. 1998. [PNP deficiency].. Ryoikibetsu Shokogun Shirizu PMID: 9833477
- 8. Itsko M et al.. 2017. Suppressors of dGTP Starvation in Escherichia coli.. J Bacteriol 199(12) PMID: 28373271
